Literature DB >> 24004160

Superficial dermal fibroblasts enhance basement membrane and epidermal barrier formation in tissue-engineered skin: implications for treatment of skin basement membrane disorders.

Mathew Varkey1, Jie Ding, Edward E Tredget.   

Abstract

Basement membrane is a highly specialized structure that binds the dermis and the epidermis of the skin, and is mainly composed of laminins, nidogen, collagen types IV and VII, and the proteoglycans, collagen type XVIII and perlecan, all of which play critical roles in the function and resilience of skin. Both dermal fibroblasts and epidermal keratinocytes contribute to the development of the basement membrane, and in turn the basement membrane and underlying dermis influence the development and function of the epidermal barrier. Disruption of the basement membrane results in skin fragility, extensive painful blistering, and severe recurring wounds as seen in skin basement membrane disorders such as epidermolysis bullosa, a family of life-threatening congenital skin disorders. Currently, there are no successful strategies for treatment of these disorders; we propose the use of tissue-engineered skin as a promising approach for effective wound coverage and to enhance healing. Fibroblasts and keratinocytes isolated from superficial and deep dermis and epidermis, respectively, of tissue from abdominoplasty patients were independently cocultured on collagen-glycosaminoglycan matrices, and the resulting tissue-engineered skin was assessed for functional differences based on the underlying specific dermal fibroblast subpopulation. Tissue-engineered skin with superficial fibroblasts and keratinocytes formed a continuous epidermis with increased epidermal barrier function and expressed higher levels of epidermal proteins, keratin-5, and E-cadherin, compared to that with deep fibroblasts and keratinocytes, which had an intermittent epidermis. Further, tissue-engineered skin with superficial fibroblasts and keratinocytes formed better basement membrane, and produced more laminin-5, nidogen, collagen type VII, compared to that with deep fibroblasts and keratinocytes. Overall, our results demonstrate that tissue-engineered skin with superficial fibroblasts and keratinocytes forms significantly better basement membrane with higher expression of dermo-epidermal adhesive and anchoring proteins, and superior epidermis with enhanced barrier function compared to that with deep fibroblasts and keratinocytes, or with superficial fibroblasts, deep fibroblasts, and keratinocytes. The specific use of superficial fibroblasts in tissue-engineered skin may thus be more beneficial to promote adhesion of newly formed skin and wound healing, and is therefore promising for the treatment of patients with basement membrane disorders and other skin blistering diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24004160      PMCID: PMC3926179          DOI: 10.1089/ten.TEA.2013.0160

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  56 in total

1.  Small leucine-rich proteoglycans, decorin and fibromodulin, are reduced in postburn hypertrophic scar.

Authors:  Dariush Honardoust; Mathew Varkey; Keijiro Hori; Jie Ding; Heather A Shankowsky; Edward E Tredget
Journal:  Wound Repair Regen       Date:  2011-04-21       Impact factor: 3.617

Review 2.  Progress in epidermolysis bullosa research: toward treatment and cure.

Authors:  Jouni Uitto; John A McGrath; Ulrich Rodeck; Leena Bruckner-Tuderman; E Clare Robinson
Journal:  J Invest Dermatol       Date:  2010-04-15       Impact factor: 8.551

Review 3.  Inherited epidermolysis bullosa: past, present, and future.

Authors:  Jo-David Fine
Journal:  Ann N Y Acad Sci       Date:  2010-04       Impact factor: 5.691

4.  Gene therapy of inherited skin adhesion disorders: a critical overview.

Authors:  M De Luca; G Pellegrini; F Mavilio
Journal:  Br J Dermatol       Date:  2009-04-20       Impact factor: 9.302

5.  Deep dermal fibroblasts contribute to hypertrophic scarring.

Authors:  JianFei Wang; Carole Dodd; Heather A Shankowsky; Paul G Scott; Edward E Tredget
Journal:  Lab Invest       Date:  2008-10-27       Impact factor: 5.662

6.  Differential collagen-glycosaminoglycan matrix remodeling by superficial and deep dermal fibroblasts: potential therapeutic targets for hypertrophic scar.

Authors:  Mathew Varkey; Jie Ding; Edward E Tredget
Journal:  Biomaterials       Date:  2011-07-30       Impact factor: 12.479

7.  Human hypertrophic scar-like nude mouse model: characterization of the molecular and cellular biology of the scar process.

Authors:  JianFei Wang; Jie Ding; Haiyan Jiao; Dariush Honardoust; Moein Momtazi; Heather A Shankowsky; Edward E Tredget
Journal:  Wound Repair Regen       Date:  2011 Mar-Apr       Impact factor: 3.617

8.  Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa wounds.

Authors:  A F Falabella; I C Valencia; W H Eaglstein; L A Schachner
Journal:  Arch Dermatol       Date:  2000-10

Review 9.  Diverse cell signaling events modulated by perlecan.

Authors:  John M Whitelock; James Melrose; Renato V Iozzo
Journal:  Biochemistry       Date:  2008-10-01       Impact factor: 3.162

10.  Preparation of keratinocyte culture medium for the clinical applications of regenerative medicine.

Authors:  Ryo Takagi; Masayuki Yamato; Daisuke Murakami; Makoto Kondo; Joseph Yang; Takeshi Ohki; Kohji Nishida; Chinatsu Kohno; Teruo Okano
Journal:  J Tissue Eng Regen Med       Date:  2010-08-26       Impact factor: 3.963

View more
  8 in total

1.  Keratinocyte Microvesicles Regulate the Expression of Multiple Genes in Dermal Fibroblasts.

Authors:  Ping Huang; Jiarui Bi; Gethin R Owen; Weimin Chen; Anne Rokka; Leeni Koivisto; Jyrki Heino; Lari Häkkinen; Hannu Larjava
Journal:  J Invest Dermatol       Date:  2015-08-19       Impact factor: 8.551

2.  Advancing biomaterials of human origin for tissue engineering.

Authors:  Fa-Ming Chen; Xiaohua Liu
Journal:  Prog Polym Sci       Date:  2015-03-28       Impact factor: 29.190

3.  Quantitative monitoring of laser-treated engineered skin using optical coherence tomography.

Authors:  Yujin Ahn; Chan-Young Lee; Songyee Baek; Taeho Kim; Pilun Kim; Sunghoon Lee; Daejin Min; Haekwang Lee; Jeehyun Kim; Woonggyu Jung
Journal:  Biomed Opt Express       Date:  2016-02-24       Impact factor: 3.732

4.  The survey on cellular and engineered tissue therapies in Europe in 2012.

Authors:  Ivan Martin; Hilary Ireland; Helen Baldomero; Jakob Passweg
Journal:  Tissue Eng Part A       Date:  2015-01       Impact factor: 3.845

Review 5.  Biology and principles of scar management and burn reconstruction.

Authors:  Edward E Tredget; Benjamin Levi; Matthias B Donelan
Journal:  Surg Clin North Am       Date:  2014-08       Impact factor: 2.741

Review 6.  Advances in Skin Substitutes-Potential of Tissue Engineered Skin for Facilitating Anti-Fibrotic Healing.

Authors:  Mathew Varkey; Jie Ding; Edward E Tredget
Journal:  J Funct Biomater       Date:  2015-07-09

7.  Interplay Between Keratinocytes and Fibroblasts: A Systematic Review Providing a New Angle for Understanding Skin Fibrotic Disorders.

Authors:  Barbara Russo; Nicolò C Brembilla; Carlo Chizzolini
Journal:  Front Immunol       Date:  2020-05-06       Impact factor: 7.561

8.  Evaluation of native and non-native biomaterials for engineering human skin tissue.

Authors:  Carolina Motter Catarino; Katharina Kaiser; Tânia Baltazar; Luiza Motter Catarino; Jonathan R Brewer; Pankaj Karande
Journal:  Bioeng Transl Med       Date:  2022-02-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.